Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Publication Type:

Journal Article

Source:

Journal of the National Cancer Institute, Volume 101, Issue 14, p.984-92 (2009)

Keywords:

2009, Adult, African Americans, Aged, Breast Neoplasms, Clinical Trials, Phase III as Topic, Colorectal Neoplasms, Confidence Intervals, Confounding Factors (Epidemiology), Educational Status, European Continental Ancestry Group, Female, Health Status Disparities, Humans, Income, Kaplan-Meier Estimate, LEUKEMIA, Lung Neoplasms, Lymphoma, Male, Middle Aged, Multiple Myeloma, Neoplasm Staging, Neoplasms, Odds Ratio, Ovarian Neoplasms, Prognosis, Proportional Hazards Models, Prostatic Neoplasms, Public Health Sciences Division, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Socioeconomic Factors, Survival Rate, United States

Abstract:

Racial disparities in cancer outcomes have been observed in several malignancies. However, it is unclear if survival differences persist after adjusting for clinical, demographic, and treatment variables. Our objective was to determine whether racial disparities in survival exist among patients enrolled in consecutive trials conducted by the Southwest Oncology Group (SWOG).